GlassScriptPhysician profile
Abhijit Ghatak
NPI 1497902084
$4,262.64
in general payments reported to CMS, 2019-2025
36 companies · $707 in 2025
The $707 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $158 · 2021: $871 · 2022: $612 · 2023: $919 · 2024: $652 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,278.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $403.27 | 2021-2024 | Cardiomems, Assurity |
| Amgen INC. | $395.84 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $357.60 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $329.49 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $313.28 | 2019-2025 | Watchman Access System, Watchman Flx, Varithena Administration Pack |
| Pfizer INC. | $277.14 | 2020-2025 | |
| Edwards Lifesciences Corporation | $257.16 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Shockwave Medical, INC | $203.17 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $197.34 | 2019-2025 | Lifevest |
| Medtronic, INC. | $158.64 | 2025 | Micra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.43 | 2022-2025 | Jardiance |
| Abiomed | $141.46 | 2020-2024 | Impella |
| Impulse Dynamics (USA) INC. | $140.05 | 2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $104.77 | 2021-2025 | |
| Heartflow, INC. | $96.92 | 2023 | Ffrct |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $76.03 | 2021-2025 | Optowire |
| Amarin Pharma, INC. | $73.05 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $71.03 | 2022-2024 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $60.33 | 2022-2025 | Camzyos |
| Philips North America LLC | $46.15 | 2022-2023 | |
| Novo Nordisk INC | $45.97 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Cordis US Corp. | $41.47 | 2025 | Mynx Control Venous, Mynx Control |
| Scpharmaceuticals INC. | $37.22 | 2023-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $35.23 | 2021-2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $34.31 | 2021-2024 | Wainua |
| Astellas Pharma US INC | $23.90 | 2019 | |
| Irhythm Technologies, INC. | $22.86 | 2023 | Zio Xt Patch |
| Lilly USA, LLC | $21.27 | 2023 | Mounjaro |
| Lexicon Pharmaceuticals, INC. | $20.98 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $20.21 | 2021 | |
| Kestra Medical Technology Services, INC. | $19.80 | 2024 | Assure Wcd |
| Daiichi Sankyo INC. | $19.28 | 2023 | Injectafer |
| Chiesi USA, INC. | $18.21 | 2025 | Kengreal |
| Kiniksa Pharmaceuticals International, Plc | $17.73 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $15.62 | 2025 | Nexletol |
| Davol INC. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhijit Ghatak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.